Intrinsic value of Select Medical Holdings - SEM

Previous Close

$19.36

  Intrinsic Value

$85.75

stock screener

  Rating & Target

str. buy

+343%

Previous close

$19.36

 
Intrinsic value

$85.75

 
Up/down potential

+343%

 
Rating

str. buy

We calculate the intrinsic value of SEM stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 2.6

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  17.60
  16.34
  15.21
  14.19
  13.27
  12.44
  11.70
  11.03
  10.42
  9.88
  9.39
  8.95
  8.56
  8.20
  7.88
  7.59
  7.33
  7.10
  6.89
  6.70
  6.53
  6.38
  6.24
  6.12
  6.01
  5.90
  5.81
  5.73
  5.66
  5.59
Revenue, $m
  5,226
  6,080
  7,004
  7,998
  9,059
  10,185
  11,377
  12,631
  13,948
  15,326
  16,766
  18,267
  19,830
  21,457
  23,148
  24,906
  26,733
  28,632
  30,605
  32,656
  34,789
  37,008
  39,318
  41,723
  44,228
  46,839
  49,563
  52,404
  55,370
  58,467
Variable operating expenses, $m
  3,305
  3,795
  4,324
  4,894
  5,502
  6,147
  6,830
  7,549
  8,303
  9,093
  9,607
  10,468
  11,363
  12,295
  13,265
  14,272
  15,319
  16,407
  17,537
  18,713
  19,935
  21,207
  22,530
  23,908
  25,344
  26,840
  28,401
  30,029
  31,728
  33,503
Fixed operating expenses, $m
  1,286
  1,314
  1,343
  1,372
  1,403
  1,433
  1,465
  1,497
  1,530
  1,564
  1,598
  1,633
  1,669
  1,706
  1,744
  1,782
  1,821
  1,861
  1,902
  1,944
  1,987
  2,030
  2,075
  2,121
  2,167
  2,215
  2,264
  2,314
  2,365
  2,417
Total operating expenses, $m
  4,591
  5,109
  5,667
  6,266
  6,905
  7,580
  8,295
  9,046
  9,833
  10,657
  11,205
  12,101
  13,032
  14,001
  15,009
  16,054
  17,140
  18,268
  19,439
  20,657
  21,922
  23,237
  24,605
  26,029
  27,511
  29,055
  30,665
  32,343
  34,093
  35,920
Operating income, $m
  635
  971
  1,337
  1,731
  2,154
  2,605
  3,082
  3,585
  4,114
  4,669
  5,560
  6,166
  6,798
  7,456
  8,140
  8,852
  9,593
  10,364
  11,165
  11,999
  12,867
  13,771
  14,712
  15,694
  16,717
  17,784
  18,898
  20,061
  21,277
  22,547
EBITDA, $m
  1,061
  1,416
  1,802
  2,219
  2,665
  3,140
  3,644
  4,175
  4,733
  5,318
  5,931
  6,569
  7,236
  7,929
  8,651
  9,402
  10,183
  10,996
  11,841
  12,720
  13,635
  14,588
  15,581
  16,615
  17,693
  18,818
  19,992
  21,218
  22,499
  23,838
Interest expense (income), $m
  143
  156
  199
  246
  297
  351
  410
  472
  538
  607
  680
  756
  835
  918
  1,004
  1,094
  1,187
  1,284
  1,385
  1,490
  1,598
  1,712
  1,829
  1,952
  2,079
  2,212
  2,350
  2,494
  2,644
  2,801
  2,964
Earnings before tax, $m
  479
  772
  1,091
  1,435
  1,803
  2,195
  2,610
  3,047
  3,507
  3,989
  4,805
  5,331
  5,880
  6,451
  7,046
  7,665
  8,309
  8,979
  9,676
  10,401
  11,156
  11,942
  12,761
  13,615
  14,505
  15,434
  16,404
  17,417
  18,476
  19,583
Tax expense, $m
  129
  209
  295
  387
  487
  593
  705
  823
  947
  1,077
  1,297
  1,439
  1,588
  1,742
  1,903
  2,070
  2,243
  2,424
  2,612
  2,808
  3,012
  3,224
  3,445
  3,676
  3,916
  4,167
  4,429
  4,703
  4,989
  5,287
Net income, $m
  350
  564
  797
  1,047
  1,316
  1,602
  1,905
  2,224
  2,560
  2,912
  3,507
  3,892
  4,292
  4,710
  5,144
  5,596
  6,066
  6,555
  7,063
  7,593
  8,144
  8,717
  9,315
  9,939
  10,589
  11,267
  11,975
  12,715
  13,487
  14,295

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,027
  7,012
  8,078
  9,224
  10,448
  11,748
  13,122
  14,569
  16,088
  17,677
  19,338
  21,069
  22,873
  24,749
  26,699
  28,727
  30,834
  33,024
  35,300
  37,665
  40,126
  42,685
  45,349
  48,123
  51,013
  54,025
  57,166
  60,443
  63,864
  67,436
Adjusted assets (=assets-cash), $m
  6,027
  7,012
  8,078
  9,224
  10,448
  11,748
  13,122
  14,569
  16,088
  17,677
  19,338
  21,069
  22,873
  24,749
  26,699
  28,727
  30,834
  33,024
  35,300
  37,665
  40,126
  42,685
  45,349
  48,123
  51,013
  54,025
  57,166
  60,443
  63,864
  67,436
Revenue / Adjusted assets
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
  0.867
Average production assets, $m
  2,885
  3,356
  3,866
  4,415
  5,000
  5,622
  6,280
  6,972
  7,699
  8,460
  9,255
  10,083
  10,946
  11,844
  12,778
  13,748
  14,757
  15,805
  16,894
  18,026
  19,203
  20,428
  21,703
  23,031
  24,414
  25,855
  27,359
  28,927
  30,564
  32,274
Working capital, $m
  287
  334
  385
  440
  498
  560
  626
  695
  767
  843
  922
  1,005
  1,091
  1,180
  1,273
  1,370
  1,470
  1,575
  1,683
  1,796
  1,913
  2,035
  2,162
  2,295
  2,433
  2,576
  2,726
  2,882
  3,045
  3,216
Total debt, $m
  3,482
  4,309
  5,203
  6,165
  7,192
  8,282
  9,435
  10,649
  11,923
  13,257
  14,650
  16,103
  17,616
  19,190
  20,826
  22,528
  24,295
  26,133
  28,042
  30,027
  32,091
  34,238
  36,473
  38,801
  41,225
  43,752
  46,388
  49,137
  52,007
  55,004
Total liabilities, $m
  5,057
  5,883
  6,778
  7,739
  8,766
  9,857
  11,009
  12,223
  13,497
  14,831
  16,224
  17,677
  19,190
  20,764
  22,401
  24,102
  25,870
  27,707
  29,616
  31,601
  33,665
  35,813
  38,048
  40,375
  42,800
  45,327
  47,962
  50,712
  53,582
  56,579
Total equity, $m
  970
  1,129
  1,301
  1,485
  1,682
  1,891
  2,113
  2,346
  2,590
  2,846
  3,113
  3,392
  3,682
  3,985
  4,299
  4,625
  4,964
  5,317
  5,683
  6,064
  6,460
  6,872
  7,301
  7,748
  8,213
  8,698
  9,204
  9,731
  10,282
  10,857
Total liabilities and equity, $m
  6,027
  7,012
  8,079
  9,224
  10,448
  11,748
  13,122
  14,569
  16,087
  17,677
  19,337
  21,069
  22,872
  24,749
  26,700
  28,727
  30,834
  33,024
  35,299
  37,665
  40,125
  42,685
  45,349
  48,123
  51,013
  54,025
  57,166
  60,443
  63,864
  67,436
Debt-to-equity ratio
  3.590
  3.820
  4.000
  4.150
  4.280
  4.380
  4.470
  4.540
  4.600
  4.660
  4.710
  4.750
  4.780
  4.820
  4.840
  4.870
  4.890
  4.920
  4.930
  4.950
  4.970
  4.980
  5.000
  5.010
  5.020
  5.030
  5.040
  5.050
  5.060
  5.070
Adjusted equity ratio
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161
  0.161

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  350
  564
  797
  1,047
  1,316
  1,602
  1,905
  2,224
  2,560
  2,912
  3,507
  3,892
  4,292
  4,710
  5,144
  5,596
  6,066
  6,555
  7,063
  7,593
  8,144
  8,717
  9,315
  9,939
  10,589
  11,267
  11,975
  12,715
  13,487
  14,295
Depreciation, amort., depletion, $m
  426
  445
  466
  488
  511
  536
  562
  590
  619
  649
  370
  403
  438
  474
  511
  550
  590
  632
  676
  721
  768
  817
  868
  921
  977
  1,034
  1,094
  1,157
  1,223
  1,291
Funds from operations, $m
  776
  1,009
  1,262
  1,535
  1,827
  2,138
  2,467
  2,814
  3,179
  3,562
  3,878
  4,295
  4,730
  5,183
  5,655
  6,146
  6,656
  7,187
  7,739
  8,314
  8,912
  9,535
  10,184
  10,860
  11,565
  12,301
  13,069
  13,872
  14,710
  15,586
Change in working capital, $m
  43
  47
  51
  55
  58
  62
  66
  69
  72
  76
  79
  83
  86
  89
  93
  97
  100
  104
  109
  113
  117
  122
  127
  132
  138
  144
  150
  156
  163
  170
Cash from operations, $m
  733
  962
  1,211
  1,480
  1,769
  2,076
  2,402
  2,745
  3,107
  3,486
  3,798
  4,212
  4,644
  5,094
  5,562
  6,049
  6,555
  7,082
  7,630
  8,201
  8,794
  9,413
  10,056
  10,728
  11,427
  12,158
  12,920
  13,715
  14,547
  15,416
Maintenance CAPEX, $m
  -98
  -115
  -134
  -155
  -177
  -200
  -225
  -251
  -279
  -308
  -338
  -370
  -403
  -438
  -474
  -511
  -550
  -590
  -632
  -676
  -721
  -768
  -817
  -868
  -921
  -977
  -1,034
  -1,094
  -1,157
  -1,223
New CAPEX, $m
  -432
  -471
  -510
  -548
  -586
  -622
  -658
  -692
  -727
  -761
  -795
  -829
  -863
  -898
  -934
  -970
  -1,008
  -1,048
  -1,089
  -1,132
  -1,177
  -1,225
  -1,275
  -1,328
  -1,383
  -1,442
  -1,503
  -1,568
  -1,637
  -1,710
Cash from investing activities, $m
  -530
  -586
  -644
  -703
  -763
  -822
  -883
  -943
  -1,006
  -1,069
  -1,133
  -1,199
  -1,266
  -1,336
  -1,408
  -1,481
  -1,558
  -1,638
  -1,721
  -1,808
  -1,898
  -1,993
  -2,092
  -2,196
  -2,304
  -2,419
  -2,537
  -2,662
  -2,794
  -2,933
Free cash flow, $m
  203
  375
  567
  777
  1,006
  1,254
  1,519
  1,802
  2,101
  2,417
  2,665
  3,014
  3,378
  3,758
  4,155
  4,567
  4,997
  5,444
  5,909
  6,393
  6,896
  7,419
  7,964
  8,532
  9,123
  9,739
  10,382
  11,053
  11,753
  12,484
Issuance/(repayment) of debt, $m
  753
  826
  895
  961
  1,027
  1,091
  1,153
  1,214
  1,274
  1,334
  1,393
  1,453
  1,513
  1,574
  1,637
  1,701
  1,768
  1,837
  1,909
  1,985
  2,064
  2,147
  2,235
  2,327
  2,425
  2,527
  2,635
  2,750
  2,870
  2,997
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  753
  826
  895
  961
  1,027
  1,091
  1,153
  1,214
  1,274
  1,334
  1,393
  1,453
  1,513
  1,574
  1,637
  1,701
  1,768
  1,837
  1,909
  1,985
  2,064
  2,147
  2,235
  2,327
  2,425
  2,527
  2,635
  2,750
  2,870
  2,997
Total cash flow (excl. dividends), $m
  956
  1,202
  1,461
  1,739
  2,033
  2,344
  2,672
  3,016
  3,375
  3,751
  4,058
  4,466
  4,891
  5,332
  5,791
  6,269
  6,765
  7,281
  7,818
  8,378
  8,960
  9,567
  10,199
  10,859
  11,548
  12,267
  13,017
  13,802
  14,623
  15,481
Retained Cash Flow (-), $m
  -147
  -159
  -172
  -184
  -197
  -209
  -221
  -233
  -245
  -256
  -267
  -279
  -290
  -302
  -314
  -326
  -339
  -353
  -366
  -381
  -396
  -412
  -429
  -447
  -465
  -485
  -506
  -528
  -551
  -575
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  809
  1,043
  1,290
  1,554
  1,836
  2,135
  2,451
  2,783
  3,131
  3,495
  3,791
  4,188
  4,600
  5,030
  5,477
  5,942
  6,426
  6,929
  7,452
  7,997
  8,564
  9,155
  9,771
  10,413
  11,082
  11,782
  12,512
  13,275
  14,072
  14,906
Discount rate, %
  11.10
  11.66
  12.24
  12.85
  13.49
  14.17
  14.88
  15.62
  16.40
  17.22
  18.08
  18.98
  19.93
  20.93
  21.98
  23.08
  24.23
  25.44
  26.71
  28.05
  29.45
  30.92
  32.47
  34.09
  35.80
  37.59
  39.47
  41.44
  43.51
  45.69
PV of cash for distribution, $m
  728
  837
  912
  958
  975
  964
  928
  871
  798
  714
  609
  520
  433
  352
  278
  214
  161
  117
  83
  57
  38
  24
  15
  9
  5
  3
  2
  1
  0
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company's segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. The Concentra segment consists of medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics (CBOCs) that deliver occupational medicine, physical therapy, veteran's healthcare, and consumer health services. As of December 31, 2016, the Company had operations in 46 states and the District of Columbia.

FINANCIAL RATIOS  of  Select Medical Holdings (SEM)

Valuation Ratios
P/E Ratio 22.3
Price to Sales 0.6
Price to Book 3.1
Price to Tangible Book
Price to Cash Flow 7.4
Price to Free Cash Flow 13.9
Growth Rates
Sales Growth Rate 14.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -11.5%
Cap. Spend. - 3 Yr. Gr. Rate 17%
Financial Strength
Quick Ratio 2
Current Ratio 0.1
LT Debt to Equity 329%
Total Debt to Equity 335.5%
Interest Coverage 2
Management Effectiveness
Return On Assets 4.6%
Ret/ On Assets - 3 Yr. Avg. 5.3%
Return On Total Capital 3.4%
Ret/ On T. Cap. - 3 Yr. Avg. 4.5%
Return On Equity 13.7%
Return On Equity - 3 Yr. Avg. 15.3%
Asset Turnover 0.9
Profitability Ratios
Gross Margin 14.5%
Gross Margin - 3 Yr. Avg. 14.8%
EBITDA Margin 10.9%
EBITDA Margin - 3 Yr. Avg. 11.2%
Operating Margin 6.7%
Oper. Margin - 3 Yr. Avg. 7.8%
Pre-Tax Margin 4.2%
Pre-Tax Margin - 3 Yr. Avg. 5.5%
Net Profit Margin 2.7%
Net Profit Margin - 3 Yr. Avg. 3.4%
Effective Tax Rate 30.9%
Eff/ Tax Rate - 3 Yr. Avg. 34.3%
Payout Ratio 0%

SEM stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the SEM stock intrinsic value calculation we used $4443.603 million for the last fiscal year's total revenue generated by Select Medical Holdings. The default revenue input number comes from 0001 income statement of Select Medical Holdings. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our SEM stock valuation model: a) initial revenue growth rate of 17.6% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 11.1%, whose default value for SEM is calculated based on our internal credit rating of Select Medical Holdings, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Select Medical Holdings.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of SEM stock the variable cost ratio is equal to 64.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $1258 million in the base year in the intrinsic value calculation for SEM stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.7% for Select Medical Holdings.

Corporate tax rate of 27% is the nominal tax rate for Select Medical Holdings. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the SEM stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for SEM are equal to 55.2%.

Life of production assets of 25 years is the average useful life of capital assets used in Select Medical Holdings operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for SEM is equal to 5.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $823.368 million for Select Medical Holdings - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 135.376 million for Select Medical Holdings is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Select Medical Holdings at the current share price and the inputted number of shares is $2.6 billion.

RELATED COMPANIES Price Int.Val. Rating
USPH U.S. Physical 117.27 94.79  hold
THC Tenet Healthca 23.75 33.79  hold
MYOK MyoKardia 57.11 26.66  str.sell
CYH Community Heal 3.59 7.04  str.buy

COMPANY NEWS

▶ Select Medical: 3Q Earnings Snapshot   [07:27PM  Associated Press]
▶ Select Medical: 2Q Earnings Snapshot   [05:05AM  Associated Press]
▶ Select Medical: 1Q Earnings Snapshot   [05:04AM  Associated Press]
▶ Select Medical beats 4Q profit forecasts   [Feb-21-18 06:03PM  Associated Press]
▶ Stocks Generating Improved Relative Strength: Select Medical   [Jan-05-18 03:00AM  Investor's Business Daily]
▶ Select Medical Sees Relative Strength Rating Climb To 74   [03:00AM  Investor's Business Daily]
▶ Select Medical Clears Key Benchmark, Hitting 80-Plus RS Rating   [Dec-07-17 03:00AM  Investor's Business Daily]
▶ Stocks With Rising Relative Price Strength: Select Medical   [Nov-30-17 03:00AM  Investor's Business Daily]
▶ Select Medical misses 3Q profit forecasts   [05:39AM  Associated Press]
▶ Select Medical beats 2Q profit forecasts   [Aug-05-17 01:13AM  Associated Press]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.